What are the risks of untreated FH? 

The primary risk of untreated familial hypercholesterolaemia (FH) is the significantly accelerated development of cardiovascular disease, leading to heart attacks and strokes at a much younger age than the general population. Because FH causes extremely high LDL (bad) cholesterol levels from birth, the coronary arteries are exposed to fatty deposits for decades. Without intervention, many individuals with the condition may experience a serious cardiac event before the age of 50. 

What We’ll Discuss in This Article 

• The cumulative impact of high LDL on the arterial walls from childhood. 

• Statistical risks of premature heart attacks in untreated men and women. 

• The development of atherosclerosis and coronary artery disease. 

• Physical complications such as tendon damage and skin xanthomas. 

• The risk of sudden cardiac death in severe or homozygous forms of FH. 

• Why FH is a ‘silent’ risk factor until an acute medical event occurs. 

• Monitoring cardiovascular health using tools like the BMI Calculator. 

Accelerated Atherosclerosis 

In the general population, the buildup of fatty plaques in the arteries (atherosclerosis) typically begins in middle age. However, in people with untreated FH, this process starts at birth. The liver’s inability to clear LDL means the blood is constantly saturated with ‘bad’ cholesterol, which slowly seeps into the artery linings. 

Over time, these deposits harden into plaques, narrowing the space for blood to flow. This is known as coronary artery disease. If a plaque ruptures, it can cause a blood clot that leads to a heart attack or stroke. Research conducted by NICE (2019) indicates that ‘the lifetime ‘cholesterol burden’ in untreated FH is often double or triple that of an unaffected individual, making early intervention essential.’ 

Statistics for Untreated Individuals 

The risk levels for untreated FH are significantly higher than for those with lifestyle-related high cholesterol.  

Estimated Risk of Cardiac Events Before Age 60 

Group	Risk of Heart Attack/Stroke (Untreated)
Men with FH	~50% by age 50
Women with FH	~30% by age 60
General Population	~1%–5% at similar ages

For men, the risk of a premature heart attack is particularly high, often occurring in their 40s or even 30s if the cholesterol levels are exceptionally elevated. While women are generally protected by hormones until menopause, their risk still remains many times higher than that of their peers without FH. 

Risks in Homozygous FH 

The most severe form of the condition, Homozygous FH (inherited from both parents), carries the most extreme risks. In these rare cases, LDL levels can be six to ten times higher than normal. Without aggressive treatment, which often includes specialized blood filtering (apheresis), individuals with Homozygous FH can develop severe heart disease or suffer sudden cardiac death during childhood or their teenage years. 

Non-Cardiac Physical Risks 

While the heart is the primary concern, untreated FH can cause complications in other parts of the body. These occur when excess cholesterol ‘overflows’ into the skin and tendons. 

• Tendon Rupture or Pain: Cholesterol deposits (xanthomas) can weaken the Achilles tendon or the tendons in the hands. This can lead to chronic pain, inflammation, or even sudden ruptures during physical activity. 

• Vision Issues: While corneal arcus (a ring around the eye) doesn’t usually affect vision directly, it is a sign of systemic vascular damage that could eventually affect the small blood vessels in the eyes. 

• Skin Lesions: Large xanthomas on the elbows, knees, or buttocks can become uncomfortable and may require specialist dermatological or surgical review if they become particularly large. 

Causes and Triggers of Complications 

The primary cause of these risks is the genetic mutation itself. However, certain triggers can cause the ‘cholesterol burden’ to lead to an event much sooner. 

• High Blood Pressure: When the arteries are already narrowed by FH, high blood pressure (hypertension) puts even more strain on the heart muscle. 

• Smoking: Chemicals in tobacco damage the arterial lining, acting as a ‘glue’ that helps LDL stick to the walls faster. 

• Diabetes: High blood sugar levels further damage the blood vessels and can worsen the lipid profile. 

• Physical Stress: Sudden, intense physical exertion in someone with undiagnosed and untreated FH can occasionally trigger a heart attack if the coronary arteries are already significantly narrowed. 

Differentiation: Treated vs. Untreated FH 

It is important to understand that the ‘risks’ mentioned above apply specifically to those who are not receiving medical care. Once FH is treated, the risk profile changes dramatically. 

Feature	Untreated FH	Treated FH (Statin + Lifestyle)
LDL Levels	Typically >5.0 mmol/L	Aim for >50% reduction
Life Expectancy	Significantly shortened	Can be near normal
Heart Attack Risk	Very High (up to 50% in men)	Reduced to near-population levels
Physical Signs	May worsen over time	Often stabilise or regress

To Summarise 

The risks of untreated FH are severe, primarily involving a high probability of premature heart attack or stroke before middle age due to accelerated atherosclerosis. For men, the risk of a cardiac event is roughly 50% by the age of 50. In rare homozygous cases, these risks can even manifest in childhood. However, these risks are almost entirely preventable; with early diagnosis and high-intensity treatment, the risk of heart disease can be reduced by up to 80%. 

If you experience sudden, crushing chest pain, difficulty breathing, or sudden weakness on one side of your body, call 999 immediately. 

You may find our free BMI Calculator helpful for monitoring your overall health, as weight management is an important secondary factor in reducing cardiovascular strain. 

Authority Snapshot 

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, and emergency care. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive care across inpatient and outpatient settings. This guide is based on 2026 clinical data regarding the long-term prognosis and risks of inherited lipid disorders.